Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers ...
Nov 09, 2021
0
67
(HealthDay)—In the United States, more patients are being diagnosed with stage I non-small cell lung cancer (NSCLC), and five-year survival for NSCLC has increased, according to a study published online Oct. 21 in JAMA ...
Nov 03, 2021
0
1
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset ...
Oct 29, 2021
0
83
Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a new study in Cancer Cell led by researchers at Massachusetts General Hospital ...
Oct 26, 2021
0
53
The U.S. Food and Drug Administration has approved Roche's Tecentriq as adjuvant treatment following surgery and platinum-based chemotherapy, for adults with Stage II-IIIA non-small cell lung cancer, as determined by an FDA-approved ...
Oct 18, 2021
0
3
Imagine you're about to go on a cross-country trip, stopping at spots along the way to admire local attractions. You'd probably want to have road atlas handy, containing maps at different scales, covering both the major highways ...
Oct 14, 2021
0
12
Combination of the KRAS inhibitor sotorasib (Lumakras) with afatinib, a pan-ErbB tyrosine kinase inhibitor, was feasible in treating non-small cell lung cancer (NSCLC) patients with mutated KRAS whose disease had progressed ...
Oct 07, 2021
0
0
Non-Hispanic Black patients with non-small cell lung cancer (NSCLC) who were treated with immunotherapy had a lower risk of death than their non-Hispanic white counterparts treated with immunotherapy, according to results ...
Oct 06, 2021
0
33
New research published in the Journal of the American Geriatrics Society found that older adults with non-small cell lung cancer often have low life-space mobility prior to starting lung cancer treatment. Life-space mobility ...
Oct 06, 2021
0
5
As tumors grow within an organ, they also release cells that enter the bloodstream. These cells can travel to other organs, seeding new tumors called metastases.
Sep 28, 2021
0
84
